Reaction
Proctocolectomy reporting signals
As of the last recalculation, Proctocolectomy appears in 299 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is ADALIMUMAB-FKJP (PRR 75.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Adalimumab-Fkjp | 43 | 75.3 | 75.4 |
| Adalimumab-Aaty | 43 | 73.7 | 73.8 |
| Adalimumab-Adaz | 43 | 66.1 | 66.1 |
| Vedolizumab | 62 | 62.9 | 63.0 |
| Ustekinumab | 54 | 44.6 | 44.6 |
| Tofacitinib Citrate | 8 | 43.6 | 43.6 |